Medtronic plc [MDT] vs Dexcom [DXCM] Detailed Stock Comparison

Medtronic plc

NYSE
Loading...

Dexcom

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Medtronic plc wins in 16 metrics, Dexcom wins in 3 metrics, with 0 ties. Medtronic plc appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricMedtronic plcDexcomBetter
P/E Ratio (TTM)26.0247.39Medtronic plc
Price-to-Book Ratio2.5510.18Medtronic plc
Debt-to-Equity Ratio59.44100.24Medtronic plc
PEG Ratio16.281.71Dexcom
EV/EBITDA15.1327.85Medtronic plc
Profit Margin (TTM)13.63%13.29%Medtronic plc
Operating Margin (TTM)18.69%18.37%Medtronic plc
EBITDA Margin (TTM)18.69%18.37%Medtronic plc
Return on Equity9.74%22.83%Dexcom
Return on Assets (TTM)4.57%6.08%Dexcom
Free Cash Flow (TTM)$5.19B$630.70MMedtronic plc
Dividend Yield3.27%N/AN/A
1-Year Return8.18%-2.45%Medtronic plc
Price-to-Sales Ratio (TTM)3.576.15Medtronic plc
Enterprise Value$142.89B$25.71BMedtronic plc
EV/Revenue Ratio4.185.98Medtronic plc
Gross Profit Margin (TTM)65.02%59.53%Medtronic plc
Revenue per Share (TTM)$27$11Medtronic plc
Earnings per Share (Diluted)$3.66$1.41Medtronic plc
Beta (Stock Volatility)0.791.49Medtronic plc
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Medtronic plc vs Dexcom Stock Performance Analysis

Loading Price Chart...

Medtronic plc
Dexcom
Medtronic plc Stock Overview | Dexcom Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medtronic plc0.71%1.25%2.30%8.16%7.45%19.02%
Dexcom0.54%-2.72%-10.58%-20.51%-2.49%-15.36%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medtronic plc8.18%15.85%-12.15%31.52%185.44%78.40%
Dexcom-2.45%-34.95%-31.15%242.65%1,848.39%2,085.53%

News Based Sentiment: Medtronic plc vs Dexcom

Medtronic plc

News based Sentiment: POSITIVE

September was a remarkably positive month for Medtronic, driven by a strong earnings beat, increased guidance, and key regulatory approvals. These developments demonstrate effective execution of strategic initiatives and reinforce the company's commitment to shareholder value, making it a compelling investment story.

View Medtronic plc News Sentiment Analysis

Dexcom

News based Sentiment: MIXED

Dexcom experienced a month of conflicting signals. While Q2 earnings beat expectations and revenue grew, concerns about regulatory delays, product safety allegations, and analyst downgrades created significant volatility and uncertainty, making it a mixed bag for investors.

View Dexcom News Sentiment Analysis

Performance & Financial Health Analysis: Medtronic plc vs Dexcom

MetricMDTDXCM
Market Information
Market Cap i$121.93B$26.16B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i8,430,9808,183,612
90 Day Avg. Volume i7,487,3505,586,657
Last Close$95.48$66.44
52 Week Range$79.29 - $96.25$57.52 - $93.25
% from 52W High-0.80%-28.75%
All-Time High$135.89 (Sep 06, 2021)$164.86 (Nov 15, 2021)
% from All-Time High-29.74%-59.70%
Growth Metrics
Quarterly Revenue Growth0.08%0.15%
Quarterly Earnings Growth0.00%0.25%
Financial Health
Profit Margin (TTM) i0.14%0.13%
Operating Margin (TTM) i0.19%0.18%
Return on Equity (TTM) i0.10%0.23%
Debt to Equity (MRQ) i59.44100.24
Cash & Liquidity
Book Value per Share (MRQ)$37.36$6.56
Cash per Share (MRQ)$6.33$7.47
Operating Cash Flow (TTM) i$7.15B$987.70M
Levered Free Cash Flow (TTM) i$4.46B$425.12M
Dividends
Last 12-Month Dividend Yield i3.27%N/A
Last 12-Month Dividend i$2.80N/A

Valuation & Enterprise Metrics Analysis: Medtronic plc vs Dexcom

MetricMDTDXCM
Price Ratios
P/E Ratio (TTM) i26.0247.39
Forward P/E i16.2832.91
PEG Ratio i16.281.71
Price to Sales (TTM) i3.576.15
Price to Book (MRQ) i2.5510.18
Market Capitalization
Market Capitalization i$121.93B$26.16B
Enterprise Value i$142.89B$25.71B
Enterprise Value Metrics
Enterprise to Revenue i4.185.98
Enterprise to EBITDA i15.1327.85
Risk & Other Metrics
Beta i0.791.49
Book Value per Share (MRQ) i$37.36$6.56

Financial Statements Comparison: Medtronic plc vs Dexcom

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)MDTDXCM
Revenue/Sales i$8.58B$1.04B
Cost of Goods Sold i$3.00B$447.00M
Gross Profit i$5.58B$589.00M
Research & Development i$726.00M$145.20M
Operating Income (EBIT) i$1.52B$133.70M
EBITDA i$2.30B$219.00M
Pre-Tax Income i$1.30B$154.30M
Income Tax i$255.00M$48.90M
Net Income (Profit) i$1.05B$105.40M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)MDTDXCM
Cash & Equivalents i$2.22B$904.90M
Total Current Assets i$23.81B$4.55B
Total Current Liabilities i$12.88B$3.04B
Long-Term Debt i$25.64B$1.36B
Total Shareholders Equity i$48.26B$2.27B
Retained Earnings i$31.48B$1.70B
Property, Plant & Equipment i$7.16B$59.10M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)MDTDXCM
Operating Cash Flow i$2.14B$167.90M
Capital Expenditures i$-459.00M$-87.00M
Free Cash Flow i$2.07B$96.80M
Debt Repayment iN/AN/A
Common Stock Repurchase i$-274.00MN/A

Short Interest & Institutional Ownership Analysis

MetricMDTDXCM
Shares Short i12.79M13.14M
Short Ratio i1.783.18
Short % of Float i0.01%0.04%
Average Daily Volume (10 Day) i8,430,9808,183,612
Average Daily Volume (90 Day) i7,487,3505,586,657
Shares Outstanding i1.28B390.70M
Float Shares i1.28B389.52M
% Held by Insiders i0.00%0.00%
% Held by Institutions i0.87%0.97%

Dividend Analysis & Yield Comparison: Medtronic plc vs Dexcom

MetricMDTDXCM
Last 12-Month Dividend i$2.80N/A
Last 12-Month Dividend Yield i3.27%N/A
3-Year Avg Annual Dividend i$2.76N/A
3-Year Avg Dividend Yield i0.83%N/A
3-Year Total Dividends i$8.28N/A
Ex-Dividend DateMar 28, 2025N/A